We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Denies Promoting Off-Label Use, Hiding Risks of Zyprexa
Eli Lilly Denies Promoting Off-Label Use, Hiding Risks of Zyprexa
December 18, 2006
Eli Lilly is denying assertions in two articles in TheNew York Times that claim the company’s own internal documents show that it sought to downplay increased diabetes risk from Zyprexa, its best-selling antipsychotic drug.